热门资讯> 正文
DermTech申请第11章破产保护
2024-06-18 20:27
- Precision dermatology company DermTech (NASDAQ:DMTK) said on Tuesday that it has filed for voluntary chapter 11 protection in the U.S. Bankruptcy Court for the District of Delaware.
- The company said that the filing is a continuation of its strategic alternatives review process.
- The board had engaged TD Cowen to explore strategic alternatives for the company in April, which also included workforce reduction.
- DermTech said it intends to continue its laboratory operations and processing orders for the DermTech Melanoma Test, while simultaneously conducting a process to sell substantially all of its assets.
- Source: Press Release
More on DermTech
- Seeking Alpha’s Quant Rating on DermTech
- Historical earnings data for DermTech
- Financial information for DermTech
- Bankruptcy filings at highest in a year as interest rates bite: S&P Global
风险及免责提示:以上内容仅代表作者的个人立场和观点,不代表华盛的任何立场,华盛亦无法证实上述内容的真实性、准确性和原创性。投资者在做出任何投资决定前,应结合自身情况,考虑投资产品的风险。必要时,请咨询专业投资顾问的意见。华盛不提供任何投资建议,对此亦不做任何承诺和保证。